Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Fill out the form below and the price of our Tirzepatide Therapy will instantly display once you submit
Tirzepatide works by signaling on two appetite and metabolic receptors at once
Skov J, Dejgaard A, Frkir J, et al
MedImpact redefines obesity care with new suite of GLP-1 solutions
Key findings include: Mean weight loss of 24.2% (approximately 58 pounds or 26.2 kg) with 12 mg weekly dose after 48 weeks Dose-dependent efficacy across 1 mg, 4 mg, 8 mg, and 12 mg dose groups At 48 weeks, 100% of participants receiving 8 mg or 12 mg achieved at least 5% weight loss 93% of participants on 12 mg achieved 15% or more weight loss , far exceeding current therapeutic benchmarks Greater weight reduction observed in participants with BMI greater than or equal to 35 compared to those with BMI below 35 The magnitude of weight loss approaches that typically observed only with bariatric-metabolic surgery, representing a potential paradigm shift in pharmacological obesity treatment[11]
designed hollow nanospheres loaded with catalytic enzymes (catSHELS), which can catalyze HO to produce oxygen microbubbles, enabling non-invasive detection of oxidative stress levels in deep tissues via ultrasound imaging [145]
